news
MG1 virus destroys HIV-infected cells that standard therapies can’t reach
Researchers from Canada try a new approach to eliminate dormant HIV-infected cells from the body using the MG1 virus.
List view / Grid view
HIV
news
CXCR7 receptor reveals potential therapeutic target to reduce brain inflammation
CXCR7 receptor identified as a potential therapeutic target for controlling multiple sclerosis, Parkinson's and AIDS...
news
gp120 protein shows promise in HIV vaccine design
Researchers have developed a vaccine candidate that spurs animals to produce antibodies against protective sugars of multiple HIV strains...
news
dCA accelerates HIV-1 suppression in chronically infected cells
Didehydro-Cortistatin A effectively suppresses production of the HIV virus in chronically infected cells and prevents viral rebound...
news
A3G protein fights HIV as monomer and dimer
A human protein A3G inhibits HIV-1 by acting as a roadblock for further replication of the virus...
news
Bryostatin-1 shows early promise for dormant HIV infection
Scientists have designed a synthetic molecule bryostatin-1 that can reactivate dormant HIV...
news
Three-in-one antibody may protect from HIV-like virus
A three-pronged antibody has been found to protect from infection with two strains of SHIV, better than individual natural antibodies...
news
HIV vaccine hurdle cleared
An international team of researchers have demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV..
news
Nanoparticles give disease-fighting properties to cells
A new biomedical tool has been developed using nanoparticles that deliver transient gene changes to targeted cells...
news
Researchers identify a new way to treat HIV
Researchers have identified a novel variant "Delta 20" that suppresses the most damaging HIV strains...
news
Novel imaging approach offers insights into HIV’s lifecycle
Scientists have used a novel live-cell fluorescent imaging system that has allowed them to identify individual particles associated with HIV...
news
Optibrium, Imperial College and DNDi to collaborate on drug development
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
news
Scientists jump hurdle in HIV vaccine design
Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design.
news
Novel antibacterial wound cover made from crustaceans
Researchers develop bacteria-fighting wound dressing made with the help of crustaceans…
news
Kymab receives $9m R+D grant from Bill & Melinda Gates Foundation
The monoclonal antibody biopharmaceutical group Kymab announced today that it has received a $9m grant from the Bill & Melinda Gates Foundation to accelerate the development of novel vaccines and therapeutics for infectious diseases, including HIV.